What is the typical dosing of indomethacin (Nonsteroidal Anti-Inflammatory Drug (NSAID)) for an adult patient with conditions such as gout or rheumatoid arthritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Indomethacin Dosing for Acute Gout

For acute gout, start indomethacin 50 mg three times daily until pain becomes tolerable, then rapidly taper and discontinue—typically within 5-7 days total. 1

Standard Dosing Regimen

The FDA-approved dosing for acute gouty arthritis is:

  • Initial phase: 50 mg three times daily (150 mg/day total) until pain is tolerable 1
  • Taper phase: Rapidly reduce dose once pain improves, then complete cessation 1
  • Expected timeline: Pain relief typically occurs within 2-4 hours, tenderness and heat subside in 24-36 hours, and swelling gradually disappears in 3-5 days 1
  • Total treatment duration: Usually 5-7 days 2

An alternative regimen supported by guidelines is 50 mg three times daily for 2-3 days, followed by 25 mg three times daily for an additional 3-5 days until symptoms resolve 2.

Treatment Initiation and Monitoring

  • Timing: Initiate treatment as soon as possible after symptom onset, ideally within 24 hours for optimal efficacy 2
  • Response assessment: Significant improvement typically occurs within 24-36 hours 2
  • Do not interrupt ongoing urate-lowering therapy during the acute attack 2

Critical Contraindications

Avoid indomethacin in patients with:

  • Severe renal impairment (eGFR <30 mL/min)—NSAIDs can exacerbate or cause acute kidney injury 3, 2
  • History of GI bleeding or active peptic ulcer disease 2
  • Heart failure—NSAIDs carry cardiovascular risks 2
  • Cirrhosis or hepatic impairment 2
  • Patients on anticoagulation 2

Adverse Effects Profile

Gastrointestinal adverse events are common with indomethacin, occurring in 55-63% of patients—significantly higher than corticosteroid alternatives 2, 4. In comparative studies, 55% of indomethacin-treated patients reported gastrointestinal adverse events at the 50 mg four times daily dose 3.

Other reported side effects include headaches and difficulty with mentation 4.

Preferred Alternative Therapies

When indomethacin is contraindicated or poorly tolerated:

  • Oral corticosteroids: Prednisolone 30-35 mg daily for 5 days provides similar efficacy with fewer adverse events (27% vs 63% adverse event rate) 3, 2
  • Low-dose colchicine: 1.2 mg loading dose followed by 0.6 mg one hour later (only if started within 36 hours of symptom onset) 2
  • Other NSAIDs: Naproxen or ibuprofen are equally effective as indomethacin with potentially fewer side effects 2

Common Pitfalls to Avoid

  • Do not continue high-dose indomethacin beyond 2-3 days—this increases adverse effect risk without additional benefit 2
  • Do not use standard NSAID doses in renal impairment—switch to corticosteroids as first-line therapy 3, 2
  • Do not initiate urate-lowering therapy during an acute attack—wait until the flare resolves 2
  • Do not fail to provide prophylaxis when starting urate-lowering therapy—this prevents recurrent flares 2

Clinical Decision Algorithm

  1. Confirm acute gout diagnosis and assess for NSAID contraindications (renal impairment, GI risk, heart failure, cirrhosis) 2
  2. If contraindications present: Use oral corticosteroids (prednisone 0.5 mg/kg/day for 5-10 days) instead 5, 2
  3. If no contraindications: Start indomethacin 50 mg three times daily 1
  4. Monitor response at 24-36 hours: Expect significant improvement in pain, tenderness, and heat 2, 1
  5. Taper rapidly once pain tolerable: Reduce dose and discontinue within 5-7 days total 1
  6. For recurrent gout (≥2 episodes/year): Discuss urate-lowering therapy after acute attack resolves 2

References

Guideline

Indomethacin Dosing for Acute Gout

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Acute Gout Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the recommended dose of Indocid (indomethacin) for an adult patient with acute gout?
What is the recommended dosage and treatment duration of Indomethacin (Nonsteroidal Anti-Inflammatory Drug (NSAID)) for acute gout attacks?
Can indomethacin be prescribed indefinitely for gout?
What are the indications, contraindications, dosages, and duration of use for Indomethacin (NSAID)/Dexamethasone (corticosteroid)?
What is the recommended dose of indomethacin (Non-Steroidal Anti-Inflammatory Drug (NSAID)) for an adult patient with acute gout?
What is the best approach to manage muscle wasting in an elderly patient with a recent history of pneumonia?
What type of corticosteroid is hydrocortisone?
What considerations and precautions should be taken when starting or modifying treatment with Selective Serotonin Reuptake Inhibitors (SSRIs) in patients?
Does concomitant use of a proton pump inhibitor (PPI) reduce the risk of gastrointestinal (GI) bleeding in an adult patient with a history of pain or inflammatory conditions taking both Meloxicam (a nonsteroidal anti-inflammatory drug (NSAID)) and Acetylsalicylic acid (ASA) (an antiplatelet agent)?
What is the recommended treatment approach for an adult patient with hepatic steatosis, potentially associated with metabolic syndrome, obesity, diabetes, or high cholesterol?
Should a patient with symptoms of a urinary tract infection (UTI), a urine culture showing 2000 colony-forming units (CFU)/ml of gamma hemolytic streptococcus, and a negative urinalysis (UA), who is undergoing hip surgery, be treated for a UTI?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.